Metabolic dysfunction-associated steatohepatitis (MASH): Difference between revisions

No edit summary
Line 2: Line 2:
[[File:Stage of liver damage high.jpg|thumb|Stages of non-alcoholic fatty liver disease, progressing from healthy, to steatosis (fat accumulation), inflammation, fibrosis and cirrhosis.]]
[[File:Stage of liver damage high.jpg|thumb|Stages of non-alcoholic fatty liver disease, progressing from healthy, to steatosis (fat accumulation), inflammation, fibrosis and cirrhosis.]]
[[File:Sobo 1906 389.png|thumb|Inferior view of the liver with surface showing lobes and impressions.]]
[[File:Sobo 1906 389.png|thumb|Inferior view of the liver with surface showing lobes and impressions.]]
[[File:Liver vascular anatomy.png|thumb|Liver vascular anatomy.]]
*Fatty liver disease due to causes other than excessive alcohol
*Fatty liver disease due to causes other than excessive alcohol
*Associated with insulin resistance and [[metabolic syndrome]]
*Associated with insulin resistance and [[metabolic syndrome]]

Revision as of 23:03, 13 November 2024

Background

Stages of non-alcoholic fatty liver disease, progressing from healthy, to steatosis (fat accumulation), inflammation, fibrosis and cirrhosis.
Inferior view of the liver with surface showing lobes and impressions.
Liver vascular anatomy.
  • Fatty liver disease due to causes other than excessive alcohol
  • Associated with insulin resistance and metabolic syndrome

Clinical Features

Differential Diagnosis

Hepatic Dysfunction

Infectious

Neoplastic

Metabolic

Biliary

  • Biliary cirrhosis

Drugs

Miscellaneous

Evaluation

  • LFTs, CBC
  • RUQ US
  • Outpatient elastography/Fibroscan

Management

  • Treat complications of portal hypertension, if present
  • Counsel on weight loss, increased coffee consumption
  • Vitamin E if known F2 fibrosis

Disposition

  • Discharge unless complications

See Also

External Links

References

  1. Tintanelli's